Fintel · Mar 7, 2026
EH
NYSE · EHAB
Enhabit, Inc.
Healthcare · Medical - Care Facilities
$13.80
Up+$0.01 (+0.07%)
Updated Oct 7, 2026, 2:38 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 486.49M
- P/E ratio
- -3.65
- Dividend yield
- 0.00%
- 52-week range
- $13.59 – $14.22
- Volume
- 1.38M
- Avg. volume
- 441.53K
Price performance · EHAB
EHAB price history
1M range · 0 trading sessions · Daily adjusted prices
EHAB does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest EHAB news
The latest Smart Investors Daily articles mentioning EHAB.
Stock researchCompany · Overview
Company
Market Activity
Research & News
EHAB research
Overview
Company profile and research snapshot.
Company profile
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $10.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 6, 2026 | TD Cowen | Hold | — |
| Feb 24, 2026 | UBS | Neutral | — |
| Feb 23, 2026 | Leerink Partners | Market Perform | — |
| Feb 23, 2026 | Jefferies | Hold | — |
| Jan 22, 2026 | Oppenheimer | Outperform | — |
News briefing
No generated briefing is available yet.
Benzinga · Mar 6, 2026
TD Cowen Downgrades Enhabit to Hold, Raises Price Target to $13.8
TD Cowen analyst Ryan Langston downgrades Enhabit (NYSE:EHAB) from Buy to Hold and raises the price target from $12 to $13.8.
ChartMill · Mar 4, 2026
Enhabit Inc (NYSE:EHAB) Reports Mixed Q4 Results Amid Pending Kinderhook Acquisition
Enhabit's Q4 2025 results show mixed earnings amid its pending $1.1 billion acquisition by Kinderhook Industries.
Benzinga · Mar 4, 2026
Enhabit Q4 Adj. EPS $0.14, Inline, Sales $270.400M Miss $270.558M Estimate
Enhabit (NYSE:EHAB) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 250 percent increase over earnings of $0.04 per share from the same period last year. The company
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
